Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins
| Autor: | Nicola Habjan, Franziska Blaeschke, Felicitas Rataj, Bruno L Cadilha, Theresa Kaeuferle, Sebastian Kobold, Jasmin Mahdawi, Tobias Feuchtinger, Robbie G. Majzner, Antonia Apfelbeck, Dana Stenger, Eva Ortner, Mohamed-Reda Benmebarek, Mareike Lepenies, Semjon Willier, Dirk Büsch |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Recombinant Fusion Proteins
Antigens CD19 Programmed Cell Death 1 Receptor Immunotherapy Adoptive Text mining CD28 Antigens Cell Line Tumor Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Correspondence Medicine Humans CD22 CAR-T RC254-282 Acute lymphocytic leukaemia business.industry Receptors IgE Anti cd19 Neoplasms. Tumors. Oncology. Including cancer and carcinogens CD28 Hematology Fusion protein Cell function Oncology Cancer research Immunotherapy business |
| Zdroj: | Blood Cancer Journal Blood Cancer Journal, Vol 11, Iss 6, Pp 1-6 (2021) |
| ISSN: | 2044-5385 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink